Ledevaksa: instructions for use

The drug "Liverax" instruction represents as a hepatoprotector, which possesses immunomodulating, cholelitholytic, hypocholesterolemic and hypolipidemic properties. The intake of this choleretic agent normalizes the level of cholesterol and the concentration of lipids, and also reduces the content of hydrophobic acids due to direct effects on the circulation of bile acids. In addition, the drug "Livedovsa" has a characteristic cytoprotective effect, stabilizes the membranes of cholangiocytes and hepatocytes and induces choleresis saturated with bicarbonates, which leads, in turn, to the removal of toxic substances through the intestine. In addition, it should be noted that this drug, due to the inhibition of the absorption process, reduces cholesterol in bile, reduces such index as the lithogenic index, stimulates the dissolution of gallstones and prevents the formation of new stones.

The lipolipidemic medicine "Livedoksa" (the instruction to it is always included) is issued in the form of a suspension and in the form of biconvex tablets of a reddish shade.

In the composition of these agents, ursodeoxycholic acid is included as the main active element . Tablets additionally contain sodium lauryl sulfate, starch, magnesium stearate, hypromellose, silicon dioxide, lactose, povidone, purified talc, titanium dioxide, cellulose, macrogol and iron oxide.

Adopting the hypocholesterolemic drug "Livedoksa" instructions for use recommends the treatment of cholangitis, cholelithiasis, autoimmune disorders and hepatitis. In addition, this hypolipidemic and immunomodulating agent helps with esophagitis, acute forms of inflammatory processes occurring in the biliary tract, and reflux gastritis. People with toxic liver damage should also start taking Liverax tablets. The instruction advises to use them and as an effective medicine for the dissolution of cholesterol stones.

In addition, this lipid-lowering drug is often prescribed for the treatment of gallbladder or liver pathologies.

Adopting a cholelitholitic "Liverax" means the instruction strictly prohibits people suffering from pancreatitis, renal insufficiency, lactase deficiency or lactose intolerance. The list of contraindications also includes a non-functioning gallbladder, pregnancy, body weight up to thirty-four kilograms and a lactation period. In addition, the use of this hypolipidemic drug is not recommended for people with an individual intolerance to ursodeoxycholic acid, liver failure or cirrhosis. In addition, this cholelitholytic drug should not be used to dissolve X-ray-positive gallstones and treat acute forms of inflammatory diseases of the bile duct, gallbladder and intestine.